From blue jeans to blue genes

Journal of Craniofacial Surgery

Volumn 20, Issue SUPPL. 1, 2009, Pages 703-706

  Boon, Laurence M ^a,b   Vikkula, Miikka ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

Angioma; Genetic; Glomangioma; Vascular anomaly; Venous malformation

Indexed keywords

CHEEK; COMPREHENSION; CONGENITAL BLOOD VESSEL MALFORMATION; CONSULTATION; CUTANEOMUCOSAL VENOUS MALFORMATION; DIFFERENTIAL DIAGNOSIS; ESTHETICS; FAMILY; FLOW KINETICS; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETICS; GLOMUVENOUS MALFORMATION; LIP; MODEL; OUTPATIENT DEPARTMENT; PAIN; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SURGICAL TECHNIQUE; TONGUE; UNITED KINGDOM; VEIN MALFORMATION; ANIMAL; ARTICLE; CONGENITAL MALFORMATION; DISEASE MODEL; GLOMUS TUMOR; HUMAN; MUTATION; SKIN; SKIN TUMOR; VASCULARIZATION; VEIN;

ANGIOPOIETIN RECEPTOR; GLMN PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DISEASE MODELS, ANIMAL; GERM-LINE MUTATION; GLOMUS TUMOR; HUMANS; RECEPTOR, TIE-2; SKIN; SKIN NEOPLASMS; VASCULAR MALFORMATIONS; VEINS;

EID: 67650735808     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e318193d7a0     Document Type: Review

References (24)

1. Boon LM, Mulliken JB, Vikkula M, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 1994;3:1583-1587
2. Vikkula M, Boon LM, Carraway KL, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181-1190
3. Dumont DJ, Anderson L, Breitman ML, et al. Assignment of the endothelial-specific protein receptor tyrosine kinase gene (TEK) to human chromosome 9p21. Genomics 1994;23:512-513
4. Boon LM, Brouillard P, Irrthum A, et al. A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1 p21-22. Am J Hum Genet 1999;65:125-133
5. Brouillard P, Olsen BR, Vikkula M. High-resolution physical and transcript map of the locus for venous malformations with glomus cells (VMGLOM) on chromosome 1p21-p22. Genomics 2000;67:96-101
6. Irrthum A, Brouillard P, Enjolras O, et al. Linkage disequilibrium narrows locus for venous malformation with glomus cells (VMGLOM) to a single 1.48 Mbp YAC. Eur J Hum Genet 2001;9:34-38
7. Brouillard P, Boon LM, Mulliken JB, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (" glomangiomas"). Am J Hum Genet 2002;70:866-874
8. McIntyre BA, Brouillard P, Aerts V, et al. Glomulin is predominantly expressed in vascular smooth muscle cells in the embryonic and adult mouse. Gene Expr Patterns 2004;4:351-358
9. Boon LM, Mulliken JB, Enjolras O, et al. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol 2004;140:971-976
10. Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 2008;144:873-877
11. Mallory SB, Enjolras O, Boon LM, et al. Congenital plaque-type glomuvenous malformations presenting in childhood. Arch Dermatol 2006;142:892-896
12. Brouillard P, Ghassibe M, Penington A, et al. Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. J Med Genet 2005;42:e13
13. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet 2007;16 Spec No. 2:R140-149
14. Brouillard P, Enjolras O, Boon LM, et al. Glomulin and glomuvenous malformation. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, eds. Inborn Errors of Development. New York: Oxford University Press, 2008:1561-1565
15. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823
16. Limaye N, Wouters V, Uebelhoer M, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nature Genetics 2009;41:118-124
17. Eerola I, Plate KH, Spiegel R, et al. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 2000;9:1351-1355
18. Irrthum A, Karkkainen MJ, Devriendt K, et al. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 2000;67:295-301
19. Irrthum A, Devriendt K, Chitayat D, et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis- lymphedema-telangiectasia. Am J Hum Genet 2003;72:1470-1478
20. Eerola I, Boon LM, Watanabe S, et al. Locus for susceptibility for familial capillary malformation ('port-wine stain') maps to 5q. Eur J Hum Genet 2002;10:375-380
21. Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation- arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240-1249
22. Boon LM, Mulliken JB, Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 2005;15:265-269
23. Revencu N, Boon LM, Mulliken JB, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 2008;29:959-965
24. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422